GENMAB A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,954 DKK | +2.04% |
|
-2.57% | -9.30% |
| Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
| Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 2,030.00 | 2,258.00 | 2,295.00 |
| Spread/Res. | -3.72% | -13.44% | -14.84% |
| Spread/Supp. | +2.04% | +5.39% | +2.73% |
| Support | 1,915.50 | 1,854.50 | 1,902.50 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
